The Dysphagia Management Market is bound to witness a CAGR of 6% between 2019-2029. The current scenario is such that technology is making inroads into the healthcare vertical, which is, in turn, reducing the cumbersome, in-person interactions with the caregiver. Telehealth is expected to outlive physical meetings in the forecast period. This would be the state of the healthcare vertical going forward.
The new report by Persistence Market Research (PMR) unveils that the worldwide revenue of the dysphagia management market to reach US$ ~3.5 Bn, by the end of 2019. It is projected that the business sector for dysphagia management is expected to grow at a healthy CAGR between 2019 and 2029, according to PMR’s research report.
Expanding presence of managed care institutions, particularly in developed economies, is fueling the demand for neglected treatments such as dysphagia management. For instance, implementation of Affordable Care Act in the U.S. has helped in successfully increasing insurance coverage because of which an increasing number of people are coming under the net of dysphagia management. According to the report, this factor majorly contributes in paving the way for growth of the dysphagia management industry by the end of 2029.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12988
- Eisai Co. Ltd.
- Becton, Dickinson and Company (BD)
- AstraZeneca Plc.
- Cipla Limited
- Nestlé (Nestlé Health Science)
- Kent Corporation (Kent Precision Foods Group, Inc.)
- Danone (Nutricia Advanced Medical Nutrition)
- Cook Group (Cook Medical Inc.)
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/12988
Increasing Number of Local Players Adding to the Competition in Dysphagia Management Landscape
Growing prevalence and rising demand for nasogastric tube and PEG tubes in primary dysphagia management have created an opportunity for local players to come with dysphagia management products at competitive rates. Apart from global market players such as Cook Medical Incorporation and Becton, Dickinson and Company, there are several other local players in the regional dysphagia management market across the globe that are catering to the local market. For example, Dr. Goyal Medical Private Limited, OR Surgicals, NeoDevices, Inc and other small players are also participating in the dysphagia management market.
According to the PMR report, in distribution channel, hospital pharmacies will dominate the supply side in the dysphagia management market by the end of 2019. Following hospital pharmacies, retail pharmacies are next expected to harness maximum share in the forecast period of 2019-2029. This is due to the growing demand for dysphagia management products avenues in developed and emerging countries.
A marked shift towards generic and OTC formulations from branded products has been noticed, owing to expiry of majority of blockbuster drugs in the dysphagia management market. Ease of manufacturing, availability of raw materials at low prices, and lower costs aiding the rapid market influx of generic drugs in lower income nations are creating growth opportunities for the dysphagia management market.
Opportunities Reside in Better Patient Compliance
According to the PMR study, Kent Precision Food Groups Inc., has setup guidelines for dysphagia diet, which state different levels of diet depending on the severity of the diseased state. These guidelines help the patient as well as the healthcare providers to have a better understanding of food selection in dysphagia management.
Major companies in the dysphagia management sector are putting efforts to meet the need of patients and healthcare personnel to get a drift in the dysphagia management market. Improving patient compliance is directly related to making diets more palatable. Companies are expected to perform better on devising innovations in taste masking. This could lead to better patient compliance among pediatric and geriatric groups needing proper dysphagia management. Development of orodispersible tablets (ODTs) that can dissolve or disintegrate rapidly in the oral cavity could help in generation of higher revenues for players in the dysphagia management market.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/12988
Other advantages of ODTs are no water is needed, no chewing is needed, improved stability, allows high drug loading, cost-effective and adaptable to existing processing and packaging machinery. Complying with these factors creates a tremendous growth opportunity for the competitors in dysphagia management sector.
Further, acceptance of such drugs among patient groups is also high due to cost effectiveness of the type of medication. Companies operating in dysphagia management are thus expected to largely benefit from development of palatable and cost-effective ODTs. PMR’s analysis also demonstrates groundbreaking views on the business sector of the dysphagia management market along with insights on key business approaches and policies by competitors in the dysphagia management business.
Access related reports-
Injectable Drug Delivery Market
The Global Injectable Drug Delivery Devices market had reached to be USD 22 Bn in 2021 and is expected to attain US$ 29 Bn by 2026, growing at a CAGR of 6% during the forecast period of 2021-26.
Flavors Into Over the Counter OTC Pharmaceuticals Market
Preference for fruit flavors in medicines is an ongoing trend in the flavors into over-the-counter (OTC) pharmaceuticals market. The consumption of fruit flavor formulations by leading manufacturers is relatively high as compared to other flavors.
CAR T-Cell Therapy Market
CAR T-Cell Therapy Market is expected to grow from US$ 1.2 Bn in 2020 to over US$ 2.8 Bn by 2031, which reflects a CAGR of around 5.6% for the next ten years.
About Us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org